2011 HCPCS G9092
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)

  • This is the 2011 version of HCPCS G9092 - please refer to the 2016 HCPCS code set for the latest version.
  • Added on Sunday, January 01, 2006
  • Status changed on Monday, January 01, 2007 to: No maintenance for this code
  • BETOS Classification: Oncology > Other
  • Medicare coverage status: Carrier judgment

  G9091    G9093